Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye
health company dedicated to helping people see better to live
better, today announced the U.S. launch of Blink NutriTears, a
clinically proven over-the-counter supplement that targets the key
root causes of dry eyes, promotes healthy tear production and
provides noticeable relief of eye dryness symptoms in as little as
two to four weeks.1,2*
“We offer dry eye sufferers a wide array of options that target
the ocular surface, but many consumers are looking for options that
go beyond eye drops,” said John Ferris, executive vice president,
Consumer, Bausch + Lomb. “With Blink NutriTears, consumers now have
a first-of-its-kind clinically proven nutritional supplement that
helps hydrate their eyes from within and provides long-lasting
relief. It will be an outstanding complement to our growing dry eye
portfolio.”*
Approximately 150 million adults experience symptoms of dry eyes
in the United States. Once a condition known to traditionally
affect adults over the age of 55, dry eyes are impacting a younger
demographic of consumers fueled by modern-day factors such as
increased digital device use, environmental stressors, anxiety and
stress. Nearly 70% of consumers attribute their dry eyes to digital
device use.2
Developed in collaboration with eye care and nutritional
experts, Blink NutriTears is formulated with a proprietary blend of
ingredients, including lutein, zeaxanthin, curcumin and vitamin D,
which were shown to improve ocular symptom severity and tear film
homeostasis. It was also shown to clinically help tears stay on the
eyes for 33% longer.1*
"Blink NutriTears demonstrated consistent positive results
across two distinct studies. The clinical results are compelling -
within a month, patients achieved statistically significant dry eye
symptom relief," said Laura M. Periman, MD, cornea and refractive
fellowship trained ocular surface disease expert, and founder and
director, Dry Eye Services and Clinical Research, Periman Eye
Institute, Seattle. "With its unique formulation, I anticipate
Blink NutriTears will become an important addition to dry eye
management strategies."
“Ocular wellness, especially for dry eye patients, begins with
nutritional support. Blink NutriTears has nutrient-rich ingredients
that complement each other and have been shown to address the signs
and symptoms of dry eyes,” said Neda Gioia, OD, CNS, founder,
Integrative Vision, president, Ocular Wellness & Nutrition
Society, and Blink NutriTears clinical study investigator. “I
believe Blink NutriTears will be a game-changer for patients who
are seeking relief from symptoms of dry eyes.”
Blink NutriTears will be available in the eye care aisle or
online at most major retailers nationwide by the end of July. For
more information on Blink NutriTears, visit
https://www.justblink.com/products/blink-nutritears/.
About Dry Eyes
Dry eyes occur when the eyes do not make enough or the right
type of tears. Dry eyes are uncomfortable and can feel different to
different people. Common symptoms include pain, dryness,
irritation, burning, itching, grittiness, excessive blinking, light
sensitivity and blurry vision. Over time, if left untreated, dry
eye symptoms can become more severe and impact eye health and
vision.3
About the Blink NutriTears Clinical Study
The prospective, randomized, double-blind, parallel,
placebo-controlled clinical study evaluated the efficacy and safety
of Blink NutriTears in 155 adult participants with mild dry eye
symptoms (aged 18–65; median age 42). Participants were randomized
to receive one Blink NutriTears or placebo capsule per day for 56
days (eight weeks). Artificial tear use was also recorded. The
clinical study met both of its primary endpoints. Participants
consuming the once daily Blink NutriTears had significant
improvements in tear production, and by day 14, total Ocular
Surface Disease Index (OSDI) scores, as well as symptoms and vision
domains of the OSDI significantly improved from baseline for
participants consuming Blink NutriTears versus placebo.4*
About the Blink Brand
Blink is a leading brand that consists of lubricating eye drops
for dry eyes and dry contacts, as well as a new clinically proven
nutritional supplement. Blink eye drops are formulated to relieve
dryness and discomfort in the eyes and work by moisturizing the
surface of the eye and providing relief from irritation. Blink
NutriTears is formulated with a novel blend of ingredients
including lutein, zeaxanthin, curcumin and vitamin D, and taken
once daily provides noticeable, continuous dry eye symptom relief
from the inside out. For more information, visit
www.justblink.com.
About Bausch + Lomb
Bausch + Lomb is dedicated to protecting and enhancing the gift
of sight for millions of people around the world – from birth
through every phase of life. Its comprehensive portfolio of
approximately 400 products includes contact lenses, lens care
products, eye care products, ophthalmic pharmaceuticals,
over-the-counter products and ophthalmic surgical devices and
instruments. Founded in 1853, Bausch + Lomb has a significant
global research and development, manufacturing and commercial
footprint with approximately 13,000 employees and a presence in
nearly 100 countries. Bausch + Lomb is headquartered in Vaughan,
Ontario with corporate offices in Bridgewater, New Jersey. For more
information, visit www.bausch.com and connect with us on X,
LinkedIn, Facebook and Instagram.
Forward-looking Statements
This news release may contain forward-looking statements, which
may generally be identified by the use of the words “anticipates,”
“hopes,” “expects,” “intends,” “plans,” “should,” “could,” “would,”
“will,” “may,” “believes,” “estimates,” “potential,” “target,” or
“continue” and variations or similar expressions. These statements
are based upon the current expectations and beliefs of management
and are subject to certain risks and uncertainties that could cause
actual results to differ materially from those described in the
forward-looking statements. These risks and uncertainties include,
but are not limited to, the risks and uncertainties discussed in
Bausch + Lomb’s filings with the U.S. Securities and Exchange
Commission and the Canadian Securities Administrators, which
factors are incorporated herein by reference. Readers are cautioned
not to place undue reliance on any of these forward-looking
statements. These forward-looking statements speak only as of the
date hereof. Bausch + Lomb undertakes no obligation to update any
of these forward-looking statements to reflect events or
circumstances after the date of this news release or to reflect
actual outcomes, unless required by law.
*These statements have not been
evaluated by the Food and Drug Administration. This product is not
intended to diagnose, treat, cure or prevent any
disease.
References
- Based on a clinical study
- The 2022 Study of Dry Eye Sufferer: Multi-Sponsor Survey
Inc.
-
https://www.aoa.org/healthy-eyes/eye-and-vision-conditions/dry-eye.
- Gioia, et al. A Novel Multi-Ingredient Supplement Significantly
Improves Ocular Symptoms Severity and Tear Production in Patients
with Dry Eye Disease: Results from a Randomized, Placebo-Controlled
Clinical Trial. Front. Ophthalmol. 2024;4. doi:
10.3389/fopht.2024.1362113.
© 2024 Bausch + Lomb. BLS.0083.USA.24
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240603531891/en/
Media Contact: Kristy Marks kristy.marks@bausch.com (908)
927-0683 Investor Contact: George Gadkowski
george.gadkowski@bausch.com (877) 354-3705 (toll free) (908)
927-0735
Bausch plus Lomb (NYSE:BLCO)
過去 株価チャート
から 12 2024 まで 1 2025
Bausch plus Lomb (NYSE:BLCO)
過去 株価チャート
から 1 2024 まで 1 2025
